Search research articles
Contact Us
Filters
Showing results (11-20 of 97) with videos related to
Page
of 10
Sort By:
Urology Journal
|
June 29, 2016
Efficacy of Silodosin in Expulsive Therapy for Distal Ureteral Stones: A Randomized Double-blinded Controlled Trial
Chung Jing Wang, Po Chao Tsai, Chien Hsing Chang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity
Chien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Urologia Internationalis
|
July 31, 2009
Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study
Chung-Jing Wang, Shi-Wei Huang, Chien-Hsing Chang
Trends in Pharmacological Sciences
|
June 29, 2012
Complex and defined biostructures with the dock-and-lock method
Edmund A Rossi, David M Goldenberg, Chien-Hsing Chang
Urology
|
March 8, 2011
Randomized trial of NTrap for proximal ureteral stones
Chung-Jing Wang, Shi-Wei Huang, Chien-Hsing Chang
Urological Research
|
March 12, 2009
Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study
Chung-Jing Wang, Shi-Wei Huang, Chien-Hsing Chang
Mabs
|
March 16, 2013
Monoclonal antibodies targeting CD20
Chien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Mabs
|
December 9, 2014
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
Chien-Hsing Chang, Yang Wang, Pankaj Gupta, et al.
Blood
|
July 15, 2010
Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias
Pankaj Gupta, David M Goldenberg, Edmund A Rossi, et al.
Oncotarget
|
January 18, 2015
Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer
Donglin Liu, Chien-Hsing Chang, David V Gold, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 97) with videos related to
Sort By:
Page
of 10
Urology Journal
|
June 29, 2016
Efficacy of Silodosin in Expulsive Therapy for Distal Ureteral Stones: A Randomized Double-blinded Controlled Trial
Chung Jing Wang, Po Chao Tsai, Chien Hsing Chang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity
Chien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Urologia Internationalis
|
July 31, 2009
Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study
Chung-Jing Wang, Shi-Wei Huang, Chien-Hsing Chang
Trends in Pharmacological Sciences
|
June 29, 2012
Complex and defined biostructures with the dock-and-lock method
Edmund A Rossi, David M Goldenberg, Chien-Hsing Chang
Urology
|
March 8, 2011
Randomized trial of NTrap for proximal ureteral stones
Chung-Jing Wang, Shi-Wei Huang, Chien-Hsing Chang
Urological Research
|
March 12, 2009
Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study
Chung-Jing Wang, Shi-Wei Huang, Chien-Hsing Chang
Mabs
|
March 16, 2013
Monoclonal antibodies targeting CD20
Chien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Mabs
|
December 9, 2014
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
Chien-Hsing Chang, Yang Wang, Pankaj Gupta, et al.
Blood
|
July 15, 2010
Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias
Pankaj Gupta, David M Goldenberg, Edmund A Rossi, et al.
Oncotarget
|
January 18, 2015
Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer
Donglin Liu, Chien-Hsing Chang, David V Gold, et al.
Page
of 10